Search

Your search keyword '"V protein"' showing total 93 results

Search Constraints

Start Over You searched for: Descriptor "V protein" Remove constraint Descriptor: "V protein" Search Limiters Full Text Remove constraint Search Limiters: Full Text
93 results on '"V protein"'

Search Results

1. The W195 Residue of the Newcastle Disease Virus V Protein Is Critical for Multiple Aspects of Viral Self-Regulation through Interactions between V and Nucleoproteins.

2. Molecular biology of canine parainfluenza virus V protein and its potential applications in tumor immunotherapy

3. The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level

4. Porcine Respirovirus 1 Suppresses Host Type I Interferon Production and the JAK-STAT Signaling Pathway.

5. The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level.

6. In Silico Analysis of Plant Flavonoids as Potential Inhibitors of Newcastle Disease Virus V Protein.

7. Human Parainfluenza Virus Type 2 V Protein Modulates Iron Homeostasis.

8. Inhibition of Cavin3 Degradation by the Human Parainfluenza Virus Type 2 V Protein Is Important for Efficient Viral Growth

9. Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages.

10. Identification of a Region in the Common Amino-terminal Domain of Hendra Virus P, V, and W Proteins Responsible for Phase Transition and Amyloid Formation

11. Newcastle Disease Virus Nonstructural V Protein Upregulates SOCS3 Expression to Facilitate Viral Replication Depending on the MEK/ERK Pathway

12. Claudin-1 inhibits human parainfluenza virus type 2 dissemination.

13. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP

14. Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.

15. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.

16. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP.

17. Newcastle Disease Virus V Protein Promotes Viral Replication in HeLa Cells through the Activation of MEK/ERK Signaling.

18. Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients.

19. EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF RECOMBINANT V, THE NEWCASTLE DISEASE VIRUS NON-STRUCTURAL PROTEIN.

20. In Silico Analysis of Plant Flavonoids as Potential Inhibitors of Newcastle Disease Virus V Protein

22. Identification of a Region in the Common Amino-terminal Domain of Hendra Virus P, V, and W Proteins Responsible for Phase Transition and Amyloid Formation

23. Sendai virus V protein decreases nitric oxide production by inhibiting RIG-I signaling in infected RAW264.7 macrophages

24. Identification of amino-acid residues in the V protein of peste des petits ruminants essential for interference and suppression of STAT-mediated interferon signaling.

25. Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates

26. Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates

27. Overexpression of Newcastle disease virus (NDV) V protein enhances NDV production kinetics in chicken embryo fibroblasts.

28. Measles virus induces cell-type specific changes in gene expression

29. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus

30. Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production

31. The conserved carboxyl terminus of human parainfluenza virus type 2 V protein plays an important role in virus growth

32. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice

33. Role of V protein RNA binding in inhibition of measles virus minigenome replication

34. Inhibition of measles virus minireplicon-encoded reporter gene expression by V protein

35. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-β production

36. Masking of the contribution of V protein to sendai virus pathogenesis in an infection model with a highly virulent field isolate

37. Measles virus V protein blocks interferon (IFN)-α/β but not IFN-γ signaling by inhibiting STAT1 and STAT2 phosphorylation

38. Paramyxoviruses SV5 and HPIV2 Assemble STAT Protein Ubiquitin Ligase Complexes from Cellular Components

39. Mutational Analysis of the Sendai Virus V Protein: Importance of the Conserved Residues for Zn Binding, Virus Pathogenesis, and Efficient RNA Editing

40. Newcastle Disease Virus Nonstructural V Protein Upregulates SOCS3 Expression to Facilitate Viral Replication Depending on the MEK/ERK Pathway

41. Identification of a Region in the Common Amino-terminal Domain of Hendra Virus P, V, and W Proteins Responsible for Phase Transition and Amyloid Formation.

42. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP

43. Comparison of the immunomodulatory capabilities of the V and C proteins of different morbilliviruses

44. Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients

45. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential

46. Peste des petits ruminants virus V protein inhibits cellular antiviral response by blocking the secretion of endogenous and exogenous interferons.

47. Masking of the contribution of V protein to sendai virus pathogenesis in an infection model with a highly virulent field isolate

48. Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.

49. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice

50. Human parainfluenza virus type 2 V protein inhibits caspase-1.

Catalog

Books, media, physical & digital resources